Fundz

Boomerang Medical raises $20 million Series B co-led by Arboretum Ventures and Hatteras Venture Partners to advance its pivotal trial for neuromodulation in inflammatory bowel disease.

PRIVATESep 04, 2025

Amount Raised

$20 Million

Round Type

Series B

Mountain ViewBiotechnologyHealth Care

Investors

Arboretum VenturesHatteras Venture Partners

Description

Boomerang Medical, a women-led bioelectronic medicine company, announced a $20 million Series B financing co-led by Arboretum Ventures and Hatteras Venture Partners. The proceeds will advance the BOOM-IBD2 trial, focused on ulcerative colitis. Patients are currently being enrolled at leading medical centers across the U.S. to evaluate the potential of neuromodulation in managing symptoms.

Quick answer

Boomerang Medical raised $20 Million in a Series B round, dated September 4, 2025. Investors: Arboretum Ventures and Hatteras Venture Partners. Boomerang Medical is based in Mountain View, California, United States.

How much did Boomerang Medical raise?
Boomerang Medical raised $20 Million in a Series B round on September 4, 2025.
Who invested in Boomerang Medical?
Arboretum Ventures and Hatteras Venture Partners are named as investors in this round.
What does Boomerang Medical do?
Boomerang Medical is a women-led clinical-stage company headquartered on the campus of El Camino Hospital in Mountain View, California.
Where is Boomerang Medical based and how big is it?
Boomerang Medical is based in Mountain View, California, United States.
Who are the decision-makers at Boomerang Medical?
Fundz holds 1 contact at Boomerang Medical. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Boomerang Medical that raised within 45 days of this round, from Fundz verified event records.

  • Theriva Biologics raised $13M on October 17, 2025.
  • Adcytherix raised $122M (Series A) on October 16, 2025.
  • Bexorg raised $23M (Series A) on October 16, 2025.
  • Theriva Biologics raised $4M (Funding Round) on October 16, 2025.
  • BeSound raised $6.8M (Seed) on October 15, 2025.
  • Tubulis raised $358M (Series C) on October 15, 2025.

Who to call at Boomerang Medical, and when

A new round usually means Boomerang Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Boomerang Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Boomerang Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Boomerang Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Boomerang Medical

Location

Mountain View, California, United States

About

Boomerang Medical is a women-led clinical-stage company headquartered on the campus of El Camino Hospital in Mountain View, California. We are united by a common mission to bring new treatment options to patients with complex diseases. We are conducting clinical trials on a device-focused approach for treating autoimmune diseases by harnessing the body's own physiology through bioelectronic medicine. Boomerang Medical is Company-In-Residence at Fogarty Innovation and is backed by Arboretum Ventures and Hatteras Venture Partners.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Boomerang Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Boomerang Medical's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Boomerang Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.